011040 — Kyung Dong Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩164bn
- KR₩170bn
- KR₩194bn
- 77
- 63
- 71
- 85
Annual cashflow statement for Kyung Dong Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 12,873 | 12,627 | 12,113 | -20,730 | 5,448 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 9,085 | 6,014 | 2,136 | -1,134 | -4,281 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -11,614 | -13,230 | -22,027 | 15,984 | -14,661 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 17,116 | 12,422 | -1,075 | -31.9 | -8,074 |
| Capital Expenditures | -28,881 | -4,737 | -11,694 | -8,493 | -11,767 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -20,744 | 15,451 | -891 | 27,158 | 14,031 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -49,624 | 10,713 | -12,585 | 18,664 | 2,264 |
| Financing Cash Flow Items | -23.2 | -106 | -304 | -921 | -1,769 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -14,070 | -21,474 | 10,388 | -21,418 | 9,613 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -46,961 | 1,815 | -3,254 | -2,774 | 3,990 |